D. Takabatake

发表

Endometrial Metastasis from Breast Cancer during Adjuvant Endocrine Therapy

F. Hara, S. Takashima, S. Ohsumi, 2010, Case Reports in Oncology.

Feasibility study of docetaxel with cyclophosphamide as adjuvant chemotherapy for Japanese breast cancer patients.

N. Taira, F. Hara, H. Doihara, 2009, Japanese journal of clinical oncology.

The discordance between primary breast cancer lesions and pulmonary metastatic lesions in expression of aldehyde dehydrogenase 1-positive cancer cells

N. Taira, T. Nogami, T. Shien, 2014, Breast Cancer.

Usefulness of liquid-based cytology in hormone receptor analysis of breast cancer specimens

K. Aogi, R. Nishimura, S. Takashima, 2011, Virchows Archiv.

Efficacy and Safety of S-1 in Patients with Metastatic Breast Cancer: Retrospective Review in a Single Institution

F. Hara, S. Takashima, S. Ohsumi, 2011, Oncology.

Two cases of occult breast cancer in which PET-CT was helpful in identifying primary tumors

N. Taira, S. Takashima, S. Ohsumi, 2008, Breast cancer.

The efficacy and feasibility of dose-dense sequential chemotherapy for Japanese patients with breast cancer

N. Taira, F. Hara, T. Shien, 2018, Breast Cancer.

Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer.

F. Hara, H. Iwata, K. Yonemori, 2015, Japanese journal of clinical oncology.

Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER 2-positive metastatic breast cancer

F. Hara, H. Iwata, K. Yonemori, 2014 .

Proteasome inhibitors can alter the signaling pathways and attenuate the P‐glycoprotein‐mediated multidrug resistance

T. Fujita, H. Doihara, K. Tsukuda, 2005, International journal of cancer.

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer

T. Fujita, H. Doihara, K. Tsukuda, 2006, British Journal of Cancer.

Proteasome inhibitor bortezomib increases PTEN expression and enhances trastuzumab-induced growth inhibition in trastuzumab-resistant cells

T. Fujita, H. Doihara, K. Tsukuda, 2006, Anti-cancer drugs.

Suspicious calcifications in benign breast lesions: a radio-pathologic correlation

N. Taira, S. Takashima, S. Ohsumi, 2011, Breast cancer.

Factors associated with health-related quality-of-life in breast cancer survivors: influence of the type of surgery.

N. Taira, F. Hara, S. Takashima, 2009, Japanese journal of clinical oncology.

Phyllodes tumor of the breast: stromal overgrowth and histological classification are useful prognosis-predictive factors for local recurrence in patients with a positive surgical margin.

N. Taira, S. Takashima, S. Ohsumi, 2007, Japanese journal of clinical oncology.

Optimizing the timing of 3.6 mg Pegfilgrastim Administration for Dose-Dense Chemotherapy in Japanese Patients with Breast Cancer.

N. Taira, F. Hara, T. Shien, 2021, Acta medica Okayama.

Tumor inhibitory effect of gefitinib (ZD1839, Iressa) and taxane combination therapy in EGFR‐overexpressing breast cancer cell lines (MCF7/ADR, MDA‐MB‐231)

Daisuke Takabatake, Kensuke Kawasaki, Yutaka Ogasawara, 2007, International journal of cancer.

PTEN activity could be a predictive marker of trastuzumab efficacy in the treatment of ErbB2-overexpressing breast cancer.

T. Fujita, H. Doihara, K. Kawasaki, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Microangiopathic hemolytic anemia associated with metastatic breast cancer: case report and literature review

D. Takabatake, K. Oishi, 2016, SpringerPlus.

Less Invasive Surgery for Primary Hyperparathyroidism Based on Preoperative 99mTc-hexakis-2-methoxyisobutylisonitrile Imaging Findings

N. Taira, F. Hara, T. Shien, 2004, Surgery Today.

Determination of indication for sentinel lymph node biopsy in clinical node-negative breast cancer using preoperative 18F-fluorodeoxyglucose positron emission tomography/computed tomography fusion imaging.

N. Taira, F. Hara, S. Takashima, 2008, Japanese journal of clinical oncology.

Gasless Endoscopic Thyroid and Parathyroid Surgery Using a New Retractor

Tomoko Sasaki, Y. Kotani, Y. Usui, 2001, Surgery Today.

False-positive 18F-fluorodeoxyglucose positron emission tomography/computed tomography caused by incidental injury in a bulky intracystic carcinoma of the breast

Y. Sugawara, S. Ohsumi, R. Nishimura, 2010, Japanese Journal of Radiology.

Examination of the use of Exemestane in patients with metastatic breast cancer

F. Hara, S. Ohsumi, K. Aogi, 2011, Breast cancer.

Routine clinical use of the one‐step nucleic acid amplification assay for detection of sentinel lymph node metastases in breast cancer patients

T. Kinoshita, H. Tsuda, F. Akiyama, 2012, Cancer.

Detection of isolated ipsilateral regional lymph node recurrences by F18-fluorodeoxyglucose positron emission tomography–CT in follow-up of postoperative breast cancer patients

F. Hara, S. Takashima, S. Ohsumi, 2011, Breast Cancer Research and Treatment.

Clinical Significance of Multidetector‐Row Computed Tomography in Breast Surgery

T. Fujita, H. Doihara, N. Shimizu, 2006, Nihon rinsho. Japanese journal of clinical medicine.

Multidetector row computed tomography for diagnosing intraductal extension of breast carcinoma

Nobuyoshi Shimizu, Daisuke Takabatake, Yutaka Ogasawara, 2005, Journal of surgical oncology.

A CASE OF AGGRESSIVE ANGIOMYXOMA GROWING INTO THE PELVIC CAVITY

K. Tsukuda, N. Shimizu, D. Takabatake, 2003 .

Metastatic Breast Cancer to the Stomach Resembling Early Gastric Cancer

F. Hara, S. Takashima, S. Ohsumi, 2010, Case Reports in Oncology.

Breast biopsy for mammographically detected nonpalpable lesions using a vacuum-assisted biopsy device (Mammotome) and upright-type stereotactic mammography unit without a digital imaging system: experience of 500 biopsies

N. Taira, F. Hara, S. Ohsumi, 2014, Breast Cancer.

Contrast-enhanced CT evaluation of clinically and mammographically occult multiple breast tumors in women with unilateral early breast cancer.

Daisuke Takabatake, Takeshi Inoue, Rieko Nishimura, 2008, Japanese journal of clinical oncology.

Efficacy of lenvatinib in a patient with anaplastic thyroid cancer

D. Takabatake, K. Oishi, Y. Shibuya, 2017, Endocrinology, Diabetes & Metabolism Case Reports.

Baseline gut microbiota as a predictive marker for the efficacy of neoadjuvant chemotherapy in patients with early breast cancer: a multicenter prospective cohort study in the Setouchi Breast Project-14.

N. Taira, T. Shien, H. Doihara, 2024, Breast cancer research and treatment.

The effect of exercise and educational programs for breast cancer patients on the development of breast cancer-related lymphoedema: secondary endpoint from a randomized controlled trial in the Setouchi Breast Project-10.

N. Taira, T. Shien, H. Doihara, 2024, Breast cancer.